27th German Cancer Congress Berlin 2006
German Cancer Society (Frankfurt/M.)
22. - 26.03.2006, Berlin
New Drugs in Oncology / New Diagnosis and Modalities in Cancer Therapy
Meeting Abstract
(OP430)
[Full Text]
Inhibition of Heat-shock Protein 90 (Hsp90) with 17DMAG impairs multiple angiogenic signaling pathways in gastric cancers cells in vitro and reduces tumor growth and angiogenesis in vivo
Stöltzing O, Lang S, Klein D, Bolder U, Obed A, Gaumann A, Schlitt HJ, Geissler E[Full Text]
Meeting Abstract
(OP431)
[Full Text]
Novel Titanocene Anti-Cancer Drugs
Tacke M, Strohfeldt K, Pampillón C, Sweeney N[Full Text]
Meeting Abstract
(OP432)
[Full Text]
Efficient killing of CD22+ tumor cells by a humanized diabody-RNase fusion protein
Krauss J, Arndt MAE, Vu BK, Martin ACR, Liu H, Newton DL, Seeber S, Rybak SM, Krauss J[Full Text]
Meeting Abstract
(OP433)
[Full Text]
RAB38 represents a new target antigen for immunotherapy approaches in melanoma
Jäger D, Zippelius A, Jochims C, Knuth A[Full Text]
Meeting Abstract
(OP434)
[Full Text]
Pharmacokinetic Study of the Humanized Anti-EGF-Receptor Monoclonal Antibody Nimotuzumab in Patients (Pts) with Locally Advanced or Metastatic Pancreatic Cancer (PC)
Hilger RA, Krauss J, Scheulen ME, Bach F, Strumberg D[Full Text]
Meeting Abstract
(OP435)
[Full Text]
Influence of p21 and p53 on HDAC-mediated apoptosis in HCT116 colon cancer cells in vitro and in vivo
Ocker M, Zopf S, Neureiter D, Ganslmayer M, Hahn EG, Herold C[Full Text]
Meeting Abstract
(OP436)
[Full Text]
Hemmung des Wachstums spontaner Magenkarzinome durch den mTOR-Inhibitior Rapamycin im transgenen Tiermodell
Schwarz B, Guba M, Schroeferl S, Ischenko I, Zimmermann W, Heeschen C, Jauch KW, Bruns CJ[Full Text]
Meeting Abstract
(OP437)
[Full Text]
Growth Inhibition of Solid Tumors by Intravenous Application of cG250-TNF
Bauer S, Oosterwijk E, Stenner F, Kleber S, Pfreundschuh M, Scott A, Ritter G, Old L, Renner C[Full Text]
Meeting Abstract
(OP438)
[Full Text]
Effective tumor therapy with coagulation active Antithrombin III in a human pancreatic cancer xenograft model in SCID mice
Celik I, Dietz C, Sürücü O, Karakas E, Kalina U, Kisker O[Full Text]
Meeting Abstract
(OP439)
[Full Text]
Thermotherapy using magnetic nanoparticles, a new approach in cancer therapy
Jordan A, Wust P, Maier-Hauff K, Johannsen M, Scholz R, Gneveckow U, Thiesen B, Waldöfner N, Felix R[Full Text]
Meeting Abstract
(OP440)
[Full Text]
Tie2/tk transfected Mesenchymal Stem Cells for a combined Stem Cell/Suicide Gene Therapy of Pancreatic Carcinoma
Conrad C, Bruns C, Niess H, Huss R, von Teichert-Lüttichau I, Mojaat A, Jauch KW, Nelson P[Full Text]
Meeting Abstract
(OP441)
[Full Text]
A Clinical Phase I Study of the Triple Angiokinase Inhibitor BIBF 1120 in Advanced Cancer Patients
Mross K, Frost A, Gmehling D, Bass F, Unger C, Strecker R, Hennig J, Deichsel G, Stefanic M, Stopfer P, de Rossi L[Full Text]
Meeting Abstract
(PO442)
[Full Text]
Enzastaurin: Correlations of Chemosensitivity and Gene Expression in Human Solid Tumors
Eismann U, Oberschmidt O, Ehnert M, Fleeth J, Lüdtke FE, Struck S, Schulz L, Blatter J, Lahn MM, Ma D, Hanauske AR[Full Text]
Meeting Abstract
(PO443)
[Full Text]
Pemetrexed Combined with Paclitaxel: A Phase I Trial in Advanced Solid Tumors
Graefe T, Bolling C, Lübbing C, Yilmaz E, Müller-Hagen S, Leisner B, Blatter J, Hanauske AR[Full Text]
Meeting Abstract
(PO444)
[Full Text]
Molecular characterization of the anti-idiotypic immune response of a relapse-free neuroblastoma patient following antibody therapy. A possible vaccine against tumors of neuroectodermal origin?
Fischer P, Krueger J, Uttenreuther-Fischer MM[Full Text]
Meeting Abstract
(PO445)
[Full Text]
Combined treatment of colorectal tumors with apoptosis inducing TRAIL receptor antibodies HGS-ETR1 and HGS-ETR2 and radiotherapy: Additive effects in vitro and in vivo
Marini P, Kauder S, Schiller D, Denzinger S, Welz S, Jendrossek V, Budach W, Belka C[Full Text]
Meeting Abstract
(PO446)
[Full Text]
Antitumoral activity of the novel antitumoral compound CLU-502, isolated from Clusia rosea, in neuroblastoma and leukemia cell lines
Diaz-Carballo D, Hilger RA, Malak S, Strumberg D, Seeber S[Full Text]
Meeting Abstract
(PO447)
[Full Text]
Anti-angiogenesis Treatment with PTK/ZK in Ovarian Cancer: A Phase IB, Open Label, Safety and Pharmacokinetics (PK) Study of Escalating Doses of PTK787/ZK 222584 (PTK/ZK) in Combination With Paclitaxel and Carboplatin in Patients (pts) With Stage IC to IV Epithelial Ovarian Cancer
Schröder W, Abadie S, Witteveen PO, Campone M, Viens P, Jalava T, Masson E, Bilic S, Laurent D, du Bois A[Full Text]
Meeting Abstract
(PO448)
[Full Text]
Phase I study of four different schedules of pemetrexed, gemcitabine and cisplatin in patients with locally advanced or metastatic solid tumors
Lübbing C, Yilmaz E, Graefe T, Bolling C, Depenbrock H, Ohnmacht U, Müller-Hagen S, Hanauske AR[Full Text]
Meeting Abstract
(PO449)
[Full Text]
Syntheses of Substituted 4-(Indol-3-yl)quinazolines, a New Class of EGFR-Tyrosinkinase Inhibitors
Lüth A, Löwe W, Luger P, Weber M[Full Text]
Meeting Abstract
(PO450)
[Full Text]
Imaging controlled cancer therapy with magnetic nanoparticles
Alexiou C, Schick B, Jurgons R, Seliger C, Trahms L, Odenbach S, Iro H[Full Text]
Meeting Abstract
(PO451)
[Full Text]
Phase I trial of sorafenib (BAY 43-9006) combined with dacarbazine (DTIC) in patients with metastatic melanoma
Eisen T, Ahmad T, Marais R, Gibbens I, James M, Affolter A, Chao D, Bergamini L, Schwartz B, Gore ME[Full Text]
Meeting Abstract
(PO452)
[Full Text]
Erucylphosphocholine and erucylphosphohomocholine increase sensitivity of human malignant glioma cell lines to the cytotoxic effects of ionizing radiation
Rübel A, Handrick R, Eibl H, Budach W, Belka C, Jendrossek V[Full Text]
Meeting Abstract
(PO453)
[Full Text]
Enzastaurin, a Novel PKC-β Inhibitor, Inhibits Growth of Freshly Explanted Human Tumor Cells
Oberschmidt O, Eismann U, Ehnert M, Fleeth J, Lüdtke FE, Struck S, Schulz L, Blatter J, Lahn MM, Ma D, Hanauske AR[Full Text]
Meeting Abstract
(PO454)
[Full Text]
Anti-cancer effects of bortezomib against chemoresistant neuroblastoma cell lines in vitro and in vivo
Michaelis M, Fichtner I, Haider W, Rothweiler F, Cinatl J, Mack A, Doerr HW, Cinatl jr. J[Full Text]
Meeting Abstract
(PO455)
[Full Text]
The Effect of Src Kinase Inhibition on 5-Fluorouracil Chemosensitivity Is Related to Thymidylate Synthase Expression in Human Pancreatic Carcinoma Cells
Ischenko I, Camaj P, Guba M, Brückel M, de Toni E, Graeb C, Jauch KW, Bruns C[Full Text]
Meeting Abstract
(PO456)
[Full Text]
Endostatin - albumin fusion protein improves in vitro and in vivo effectiveness in tumor therapy
Celik I, Dietz C, Sürücü O, Mertins P, Kisker O[Full Text]
Meeting Abstract
(PO457)
[Full Text]
Efficacy of CXCR2 inhibition on tumor angiogenesis in pancreatic cancer
Albrecht U, Schwarz B, Schroeferl S, Schmid G, Baumann C, Ischenko I, Guba M, Heeschen C, Jauch KW, Bruns CJ[Full Text]
Meeting Abstract
(PO458)
[Full Text]
Clinical phase I study of a (6-maleimidocaproyl)hydrazone derivative of doxorubicin (DOXO-EMCH) in patients with advanced cancers
Unger C, Medinger M, Steinbild S, Drevs J, Häring B, Kratz F, Mross K[Full Text]
Meeting Abstract
(PO459)
[Full Text]
First patients with NF1 and malignant peripheral nerve sheath tumors treated with imantinib. Start of an open labelled phase II study
Mautner VF, Holtkamp N, Straeter R, Tatagiba M, Friedrich R, de Wit M[Full Text]
Meeting Abstract
(PO460)
[Full Text]
Taxol inhibits significantly an experimentally induced peritoneal carcinomatosis depending on the application mode
Hribaschek A, Meyer F, Pross M, Ridwelski K, Küster D, Lippert H[Full Text]
Meeting Abstract
(PO461)
[Full Text]
Bortezomib (VELCADE®, VEL) in the treatment of multiple myeloma (MM) – a prospective, non-interventional scientific study in office-based hematologists (OBH)
Knauf W, Otremba B, Overkamp F, Bammer S, Angermund R[Full Text]
Meeting Abstract
(PE462)
[Full Text]
The treatment of brain cancer with Drug-Nanoparticle complex
Singh S, Singh S, Bouazzaoui A, Kubasch J, Radunz HE, Sabel BA[Full Text]
Meeting Abstract
(PE463)
[Full Text]
Immunotherapeutic options in gastric cancer
Illert B, Meyer D, Thiede A[Full Text]
Meeting Abstract
(PE464)
[Full Text]
Selenium – A Novel Radiosensitizer?
Schüller P, Püttmann S, Micke O[Full Text]
Meeting Abstract
(PE465)
[Full Text]
Target selective activation of a TNF prodrug by urokinase type plasminogen activator (uPA) mediated proteolytic processing at the cell surface
Gerspach J, Nemeth J, Münkel S, Wajant H, Pfizenmaier K[Full Text]
Meeting Abstract
(PE466)
[Full Text]
Single-chain Fv immunoliposomes for drug delivery in cancer therapy
Kontermann R, Müller D, Baum P, Trunk G, Höfig I, Zettlitz K[Full Text]